Christopher Mendez
Papers
6
Total Citations
45
H-Index
4
About
Christopher Mendez is a radiation oncologist whose research focuses on advanced stereotactic radiation techniques for the treatment of breast and prostate cancers. His work centers on refining and validating stereotactic body radiation therapy (SBRT) and partial breast irradiation approaches to improve patient outcomes while minimizing treatment-related toxicity. Mendez's most influential contribution is his leadership in a prospective multicenter phase 1 dose-escalation trial investigating single-fraction stereotactic partial breast irradiation (S-PBI) for early-stage breast cancer using a robotic delivery system — a landmark study that has garnered 23 citations and represents a significant step toward ultra-abbreviated breast cancer treatment. His prostate cancer research is equally compelling, spanning challenging clinical scenarios including patients with inflammatory bowel disease, those with ultralarge prostate glands, cryoablation failures requiring salvage SBRT, and high-risk disease requiring nodal irradiation combined with an SBRT boost. Collectively, Mendez's body of work pushes the boundaries of what stereotactic radiation can achieve across complex patient populations, offering clinicians evidence-based guidance in areas historically lacking robust data. His research reflects a commitment to expanding access to precise, efficient, and well-tolerated radiation therapy for cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6